Clinical genetics branch support services contract

Ended Definitive Contract Awarded Last action

Contract number
00261200109D261011019
Awardee
Awarding agency
Obligated
$8,709,701

Award facts

Contract value 13% obligated
$65,127,025.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 22 -$84,623
Funding Only Action 21 $145,000
Funding Only Action 20 $420,000
Funding Only Action 19 $18,754
Funding Only Action 18 $700,000
Funding Only Action 17 $675,000
Funding Only Action 16 $600,000
Funding Only Action 15 $600,000
Funding Only Action 14 $100,000
Funding Only Action 13 $300,000
Funding Only Action 12 $175,000
Funding Only Action 11 $650,251
Funding Only Action 10 $960,000
Other Administrative Action 9 $0
Supplemental Agreement for work within scope 8 $125,000
Supplemental Agreement for work within scope 7 $382,753
Supplemental Agreement for work within scope 6 $706,566
Supplemental Agreement for work within scope 5 $700,000
Supplemental Agreement for work within scope 4 $300,000
Supplemental Agreement for work within scope 3 $175,000
Supplemental Agreement for work within scope 1 $530,000
Original award $531,000
Show all 22

About this award

This is a $65,127,025.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a professional services firm. The contract is for clinical genetics branch support services, including services such as site study setup, protocol writing, and electronic patient-reported outcomes collection for cancer clinical trials. Westat has extensive experience providing research, technical assistance, and program support services to federal agencies, particularly in public health, education, and social policy domains. The contract is not designated as a set-aside. Westat holds several Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $320 million IDV with NCI for field and biospecimen support services and a $548 million IDV for the Cancer Trials Support Unit, demonstrating the company's capacity to provide comprehensive, long-term support across various federal research and program evaluation initiatives.

Quick answers

Who was awarded contract 00261200109D261011019?

00261200109D261011019 was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2001.

How much is contract 00261200109D261011019 worth?

The government has obligated $8,709,701 on 00261200109D261011019. Its current value, with exercised options, is $65,127,025.

Was contract 00261200109D261011019 competed?

The extent of competition for 00261200109D261011019 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award